Suggested molecular targets for ASX-induced cancer prevention and treatment include NF-κB, Janus kinase (JAK)/STAT-3, phosphatidylinositide 3-kinase/protein kinase B (PI3K/Akt), MAPK, Nrf2, and PPARγ [34]. The gene discussed is AKT1; the disease is cancer.